Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco)

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Haimeur, Adil ^a,b   Messaouri, Hafida ^b   Ulmann, Lionel ^a   Mimouni, Virginie ^a   Masrar, Azelarab ^c   Chraibi, Abdelmjid ^c   Tremblin, Gérard ^a   Meskini, Nadia ^b  

^a UNIVERSITÉ DU MAINE   (France)

^b HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^c IBN SINA HOSPITAL   (Morocco)

Author keywords

Argan oil; Dyslipidemia; Oxidative stress; Platelet aggregation

Indexed keywords

ARGAN OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; MEAL; MOROCCO; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBOSIS PREVENTION;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MOROCCO; OXIDATIVE STRESS; PLANT OILS; PLATELET AGGREGATION; SAPOTACEAE; THROMBOSIS;

EID: 84880335642     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-107     Document Type: Article

References (62)

1. Anonymous, Santé en chiffres 2011 Maroc: Ministère de la santé 2012 5 180 23946388
2. Metabolic syndrome: A multiplex cardiovascular risk factor. Grundy SM, J Clin Endocrinol Metab 2007 92 399 404 17284640
3. Hypertriglyceridemia and cardiovascular risk reduction. Jacobson TA, Miller M, Schaefer EJ, Clin Ther 2007 29 763 777 10.1016/j.clinthera.2007.05.002 17697898 (Pubitemid 47232327)
4. Hyperlipidemia and coronary disease. Lacoste L, Lam JYT, Hang J, Letchacovski G, Solymoss CB, Waters D, Circulation 1995 92 3172 3177 10.1161/01.CIR.92.11.3172 7586300
5. Metabolic syndrome and dyslipidemia in youth. McNeal C, Wilson DP, J Clin Lipidol 2008 2 147 155 10.1016/j.jacl.2008.04.005 21291733 (Pubitemid 351673992)
6. Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease. Serebruany VL, Malinin A, Ong S, Atar D, J Thromb Thrombolysis 2008 25 207 213 10.1007/s11239-007-0047-3 17530178 (Pubitemid 351595984)
7. Platelet dysfunction in vascular pathologies and how can it be treated. Alexandru N, Popov D, Georgescu A, Thromb Res 2012 129 116 126 10.1016/j.thromres.2011.09.026 22035630
8. Lipoproteins, platelets, and atherothrombosis. Badimón L, Vilahur G, Padró T, Rev Esp Cardiol 2009 62 1161 1178 10.1016/S0300-8932(09) 72385-1 19793522
9. Role of the platelets in the development of atherosclerosis. Huo Y, Ley KF, Trends Cardiovasc Med 2004 14 18 22 10.1016/j.tcm.2003.09.007 14720470 (Pubitemid 38068207)
10. Inflammation in atherosclerosis. Libby P, Nature 2002 420 868 874 10.1038/nature01323 12490960 (Pubitemid 36019640)
11. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. David G, Giammarresi C, Barbagallo C, Catalano I, Cala A, Notarbartolo A, Thromb Haemost 1995 74 1015 1019 8560403
12. Platelets as initiators and mediators of inflammation at the vessel wall. Shi G, Morrell CN, Thromb Res 2011 127 387 390 10.1016/j.thromres.2010.10.019 21094986
13. Coronary heart disease prevention: Nutrients, foods and dietary patterns. Bhupathiraju SN, Tucker KL, Clin Chim Acta 2012 412 1493 1514
14. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized controlled trial. Mitjavila MT, Fandos M, Salas-Salvadós J, et al. Clin Nutr 2013 32 172 178 10.1016/j.clnu.2012.08.002 22999065
15. Dietary fatty acids and cardiovascular disease: An epidemiological approach. Erkkilä A, De Mello VDF, Risérus U, Laaksonen DE, Prog Lipid Res 2008 47 172 187 10.1016/j.plipres.2008.01.004 18328267
16. The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats. Haimeur A, Ulmann L, Mimouni V, Guéno F, Pineau-Vincent F, Meskini N, Tremblin G, Lipids Health Dis 2012 11 147 10.1186/1476-511X-11-147 23110391
17. Ethnoeconomical, ethnomedical and phytochemical study of Argania spinosa (L) skeels. Charrouf Z, Guillaume D, J Ethnopharmacol 1999 67 7 14 10.1016/S0378-8741(98)00228-1 10616955 (Pubitemid 29389738)
18. Consumption of argan oil (Morocco) with its unique profile of fatty acids tocopherols squalene sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Khallouki F, Younos C, Soulimani R, et al. Eur J Canc Prev 2003 12 67 75 10.1097/00008469-200302000-00011 (Pubitemid 36233025)
19. Prevention of chemically induced diabetes milletus in experimental animals by virgin argan oil. Bellahcen S, Mekhfi H, Ziyyat A, et al. Phytother Res 2012 26 180 185 10.1002/ptr.3524 21584872
20. Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. Berrougui H, Ettaib A, Herrena Gonzalez MD, Alvez De Sotomayor M, Bennani Kabchi N, Hmamouchi M, J Ethnopharmacol 2003 89 15 18 10.1016/S0378-8741(03)00176-4 14522427 (Pubitemid 37163794)
21. Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. Marhuenda E, Herrera MD, Br J Nut 2004 92 921 929 10.1079/BJN20041293 (Pubitemid 40028853)
22. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. Samane S, Christon R, Dombrowski L, et al. Metab Clin Exp 2009 58 909 919 10.1016/j.metabol.2009.02.013 19394055
23. Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Cherki M, Derouiche A, Drissi A, et al. Nutr Metab Cardiovasc Dis 2005 15 352 360 10.1016/j.numecd.2004.08.005 16216721 (Pubitemid 41578780)
24. Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). Drissi A, Girona J, Cherki M, et al. Clin Nutr 2004 23 1159 1166 10.1016/j.clnu.2004.03.003 15380909 (Pubitemid 39243033)
25. Nutritional intervention study with argan oil in man: effects on lipids and apolipoproteins. Derouiche A, Cherki M, Drissi A, et al. Ann Nutr Metab 2005 49 196 201 10.1159/000087072 16020940 (Pubitemid 41159837)
26. Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts. Samane S, Noël J, Charrouf Z, Amarouch H, Haddad PS, Evid Based Complement Alternat Med 2006 3 317 327 10.1093/ecam/nel015 16951716 (Pubitemid 44310275)
27. Effect of argan oil on platelet aggregation and bleeding time: A beneficial nutritional property. Mekhfi H, Gadi D, Bnouham M, Ziyyat A, Legssyer A, Aziz M, J Compl Integr Med 2008 5 1 18
28. Antithrombotic activity of argan oil: An in vivo experimental study. Mekhfi H, Belmekki F, Ziyyat A, Legssyer A, Bnouham M, Aziz M, Nutrition 2012 28 937 941 10.1016/j.nut.2011.11.032 22465906
29. ESC/EAS Guidelines for the management of dyslipidemias The task force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Reiner Z, De Backer G, Graham I, et al. Atherosclerosis 2011 217 3 46 10.1016/j.atherosclerosis.2011.06.028 21882396
30. L'arganier ressource économique et médicinale pour le Maroc. Boukhobza M, Pichon-Prun N, Phytothérapie 1988 27 21 26
31. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Richmond W, Clin Chem 1973 19 1350 1356 4757363
32. Enzymatic method of triglycerides. Trinder P, Ann Clin Biochem 1969 6 24 27
33. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Friedwald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
34. Simple and efficient method for platelet isolation from their plasma. Lagarde M, Bryon PA, Guichardant M, Dechavanne MA, Thromb Res 1980 17 581 588 10.1016/0049-3848(80)90098-5 7368178 (Pubitemid 10129052)
35. Aggregation of blood platelets by adenosine diphosphate and its reversal. Born GVR, Nature 1962 194 927 929 13871375
36. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ohkawa H, Ohishi N, Yagik K, Anal Biochem 1979 95 351 358 10.1016/0003-2697(79)90738-3 36810 (Pubitemid 9194347)
37. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Paglia DE, Valentine WN, J Lab Clin Med 1967 70 158 169 6066618
38. Dosage de l'activité glutathion-peroxydase. Chaudiére J, Gerard D, Biologie des Lipides chez l'Homme Paris: Médicales Internationales, Douste-Blazy L, Mendy F, 1988 275 289
39. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
40. The metabolic syndrome-a new worldwide definition. Alberti KG, Zimmet P, Shaw J, Lancet 2005 366 1059 1062 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
41. Antiatherogenic activity of extracts of Argania spinosa L. pericarp: beneficial effects on lipid peroxidation and cholesterol homeostasis. Berrougui H, Cherki M, Koumbadinga GA, et al. Can J Physiol Pharmacol 2007 85 918 927 10.1139/Y07-081 18066138 (Pubitemid 350189734)
42. Argan oil: which benefits on cardiovascular diseases? Cherki M, Berrougui H, Drissi A, Adlouni A, Khalil A, Pharmacol Res 2006 54 1 5 10.1016/j.phrs.2006.02.004 16554174 (Pubitemid 43850823)
43. Therapeutic potential of argan oil: A review. Elmanfalouti H, Guillaume D, Denhez C, Charrouf Z, J Pharm Pharmacol 2010 62 1669 1675 10.1111/j.2042-7158.2010.01190.x 21054392
44. High monounsaturated fatty acid diets lower both plasma cholesterol and triacyglycerol concentrations. Kris-Etherton P, Pearson TA, et al. Am J Clin Nutr 1999 70 1009 1015 10584045
45. Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: A randomized crossover study. Williams CM, Francis-Knapper JA, Webb D, et al. Br J Nutr 1999 81 439 446 10615219 (Pubitemid 29364151)
46. International conference on the healthy effect of virgin olive oil. Perez-Jimenez F, Eur J Clin Invest 2005 35 421 424 16008542 (Pubitemid 40992770)
47. Role of dietary supplements in lowering low-density lipoprotein cholesterol: A review. Nijjar PS, Burke FM, Bloesch A, Rader DJ, J Clin Lipidol 2010 4 248 258 10.1016/j.jacl.2010.07.001 21122657
48. Dietary gamma-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. Takada R, Saitoh M, Mori T, J Nutr 1994 124 469 474 8145067
49. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence. Patch CS, Tapsell LC, Williams PG, Gordon M, J Vasc Health Risk Manag 2006 2 157 162 10.2147/vhrm.2006.2.2.157 (Pubitemid 43853430)
50. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Calpe-Berdiel L, Escolà-gil JC, Blanco-Vaca F, Atherosclerosis 2009 203 18 31 10.1016/j.atherosclerosis.2008.06.026 18692849
51. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. Jones PI, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE, J Lipid Res 2000 41 697 705 10787430 (Pubitemid 30314125)
52. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia. Maki KC, Lawless AL, Reeves MS, et al. Nutrition 2013 29 96 100 10.1016/j.nut.2012.05.002 22796122
53. Free radical-lipid interactions and their pathological consequences. Rice-Evans C, Burdon C, Prog Lipid Res 1993 32 71 110 10.1016/0163-7827(93) 90006-I 8415800 (Pubitemid 23154406)
54. Essential fatty acid metabolism in patients with essential hypertension diabetes mellitus and coronary heart diseases. Das UN, Prostaglandins Leukot Essent Fatty Acids 1995 52 387 391 10.1016/0952-3278(95)90066-7 7644560
55. Influence of dietary lipids on platelet-vessel wall interaction: possible role of eicosanoids and platelet membrane fluidity. Hornstra G, Rand ML, Haemostasis 1986 16 41 42
56. In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high non-physiological concentrations. Ostertag LM, O'Kennedy N, Horgan GW, Kroon PA, Duthie GG, De Roos B, Mol Nutr Food Res 2011 55 1624 1636 10.1002/mnfr.201100135 21898791
57. Platelet aggregation in humans is affected by replacement of dietary linoleic acid with oleic acid. Burri BJ, Dougherty RM, Kelley DS, Iacono M, Am J Clin Nutr 1991 54 359 362 1858699 (Pubitemid 21898943)
58. Purification and properties of prostaglandin E§ssub§1§ esub§ / prostacyclin receptor of human blood platelets. Dutta-Roy AK, Sinha AK, J Biol Chem 1987 262 12685 12691 2887571 (Pubitemid 17147270)
59. Elevated levels of authentic plasma hydroperoxides in NIDDM. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP, Diabetes 1995 44 1054 1058 10.2337/diabetes.44.9.1054 7657028
60. Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Muruganandam A, Drouillard C, Thibert RJ, Cheung RM, Draisey TF, Mutus B, Thromb Res 1992 67 385 397 10.1016/0049-3848(92)90268-F 1357772
61. Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Berrougui H, Cloutier M, Isabelle M, Khalil A, Atherosclerosis 2006 184 389 396 10.1016/j.atherosclerosis.2005.05.018 16019008 (Pubitemid 43049725)
62. The effect of a-tocopherol supplementation on LDL oxidation a dose response study. Jialal I, Fuller CJ, Huet BA, Arterioscler Thromb Vasc Biol 1995 15 190 198 10.1161/01.ATV.15.2.190 7749825